Effect of ertugliflozin on blood pressure in patients with type 2 diabetes mellitus: a post hoc pooled analysis of randomized controlled trials

BACKGROUND: The efficacy of ertugliflozin, a sodium–glucose cotransporter 2 inhibitor, for glycemic and blood pressure (BP) control has been demonstrated in phase 3 studies. To further evaluate the effects of ertugliflozin on BP and other hemodynamic parameters, an analysis was conducted on the pool...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cardiovasc Diabetol
Hlavní autoři: Liu, Jie, Pong, Annpey, Gallo, Silvina, Darekar, Amanda, Terra, Steven G.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
Original Investigation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6503446/
https://ncbi.nlm.nih.gov/pubmed/31064361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-019-0856-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky